The draft updated guidance on assessing and preventing falls in older people and people aged 50 and over at higher risk opens ...

Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal) TA1006 12 September 2024 12 September 2024 Evinacumab for treating homozygous familial hypercholesterolaemia ...

Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal) TA1006 12 September 2024 12 September 2024 Evinacumab for treating homozygous familial hypercholesterolaemia ...

First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...

People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them. We're working with other leading health ...

For the first time, NICE has recommended a targeted treatment option for ALK-positive non-small-cell lung cancer, to be given after surgery to reduce the risk of the disease coming back. NICE ...

There is a simple discount patient access scheme for rucaparib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

The meeting will take place via Zoom, a secure web conferencing tool. You will need to join the meeting by 9:00am and it is expected to finish at approximately 1:00pm ...

All NICE products on people with learning disabilities. Includes any guidance and quality standards.

Pressure ulcers can be serious and lead to life-threatening complications, such as blood poisoning and gangrene. However, taking some simple steps can reduce the chance of pressure ulcers developing.

For the first time, NICE has recommended a targeted treatment option for ALK-positive non-small-cell lung cancer, to be given after surgery to reduce the risk of the disease coming back. Today (1 ...